Search

Your search keyword '"Wu, Frederick C. W."' showing total 26 results

Search Constraints

Start Over You searched for: Author "Wu, Frederick C. W." Remove constraint Author: "Wu, Frederick C. W." Topic hypogonadism Remove constraint Topic: hypogonadism
26 results on '"Wu, Frederick C. W."'

Search Results

1. The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort.

2. Ageing male (part 2): Management of functional hypogonadism in older men, a patient-centric holistic approach.

3. Ageing male (part I): Pathophysiology and diagnosis of functional hypogonadism.

4. Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism.

5. Clinical practice update on testosterone therapy for male hypogonadism: Contrasting perspectives to optimize care.

6. Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS.

7. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.

8. Natural history, risk factors and clinical features of primary hypogonadism in ageing men: Longitudinal Data from the European Male Ageing Study.

9. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).

10. Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone.

11. Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMAS.

12. New horizons in testosterone and the ageing male.

13. Clinical practice patterns in the assessment and management of low testosterone in men: an international survey of endocrinologists.

14. Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.

15. Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men.

16. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS).

17. Association of hypogonadism with vitamin D status: the European Male Ageing Study.

18. Identification of late-onset hypogonadism in middle-aged and elderly men.

19. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study.

20. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.

21. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.

23. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone.

24. Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men.

25. Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort.

26. Adrenal and gonadal contributions to urinary excretion and plasma concentration of epitestosterone in men — effect of adrenal stimulation and implications for detection of testosterone abuse.

Catalog

Books, media, physical & digital resources